Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Targovax Stories

2013-01-31 08:29:57

OSLO, January 31, 2013 /PRNewswire/ -- 18-24 patients will be included in the clinical Phase I/II study. Results from the Phase I part are expected in first half of 2013. Principal investigator and oncologist Svein Dueland states: "It is exciting that we now recruit patients for this study, which originates from collaboration between Oslo University Hospital and Norsk Hydro. Participation in clinical trials is an important part of the treatment we can offer cancer...